Cargando…
XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice
The recent development of new devices that are significantly less invasive, collectively termed minimally invasive glaucoma surgery, offers new perspective of intraocular pressure reduction with less risk, short operating times, and rapid recovery. The aim of this work is to provide a panoramic revi...
Autores principales: | De Gregorio, A, Pedrotti, E, Stevan, G, Bertoncello, A, Morselli, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933334/ https://www.ncbi.nlm.nih.gov/pubmed/29750009 http://dx.doi.org/10.2147/OPTH.S146919 |
Ejemplares similares
-
XEN Glaucoma Implant for the Management of Glaucoma in Naïve Patients versus Patients with Previous Glaucoma Surgery
por: Lewczuk, Katarzyna, et al.
Publicado: (2021) -
XEN Gel Stent in the management of primary open-angle glaucoma
por: Post, Michał, et al.
Publicado: (2020) -
Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR)
por: Posarelli, Chiara, et al.
Publicado: (2022) -
XEN(®)-63 Compared to XEN(®)-45 Gel Stents to Reduce Intraocular Pressure in Glaucoma
por: Evers, Charlotte, et al.
Publicado: (2023) -
Outcome of a single XEN microstent implant for glaucoma patients with different types of glaucoma
por: Schargus, Marc, et al.
Publicado: (2020)